WSLCB - Focus Group - Retail Medical Cannabis Endorsements
(March 11, 2024) - Audio - Cannabis Observer
Audio
Source
Metadata
Information Set Membership
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Information Set
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 01 - Welcome - Daniel Jacobs
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 02 - Question - HB 1453 Implementation - Brooke Davies
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 03 - Question - WAC 314-55-020 - John Kingsbury
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 04 - Comment - 5052 Retail and Medical Cannabis Endorsements - Jim MacRae
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 05 - Review - Consultant Hours Publicized - Introduction - Daniel Jacobs
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 06 - Review - Consultant Hours Publicized - Question - Enforcement - Carol Ehrhart
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 07 - Review - Consultant Hours Publicized - Comment - Enforcement - Vicki Christophersen
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 08 - Review - Consultant Hours Publicized - Comment - Cat Jeter
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 09 - Review - Consultant Hours Publicized - Comment - Jim MacRae
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 10 - Review - Consultant Hours Publicized - Comment - Appointments - Cat Jeter
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 11 - Review - Consultant Hours Publicized - Question - Posting Store Policy - Carol Ehrhart
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 12 - Rules Inbox - Daniel Jacobs
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 13 - Review - Stock Requirement - Introduction - Daniel Jacobs
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 14 - Review - Stock Requirement - Comment - Product Availability - Brooke Davies
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 15 - Review - Stock Requirement - Comment - Phase In - John Kingsbury
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 16 - Review - Stock Requirement - Comment - Carol Ehrhart
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 17 - Review - Stock Requirement - Comment - Sales of Regular Cannabis Products - Chuck Olivier
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 18 - Review - Stock Requirement - Comment - John Kingsbury
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 19 - Review - Stock Requirement - Comment - Jim MacRae
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 20 - Review - Stock Requirement - Comment - Carol Ehrhart
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 21 - Review - Stock Requirement - Comment - Vicki Christophersen
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 22 - Review - Stock Requirement - Comment - Jim MacRae
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 23 - Review - Stock Requirement - Comment - John Kingsbury
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 24 - Review - Returning to Compliance - Introduction - Daniel Jacobs
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 25 - Review - Returning to Compliance - Comment - Policy Statement - John Kingsbury
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 26 - Review - Returning to Compliance - Question - Interpretative Statement - Gregory Foster
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 27 - Review - Question - Donations to Patients - Carol Ehrhart
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 28 - Review - Question - Donations to Patients - John Kingsbury
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 29 - Review - Question - WSLCB and DOH Collaboration - Amber Wise
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 30 - Review - Question - HB 1453 Scope - Cat Jeter
- WSLCB - Focus Group - Retail Medical Cannabis Endorsements (March 11, 2024) - Segment - 31 - Wrapping Up - Daniel Jacobs